Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	May 31, 2016	May 31, 2015
Income Statement [Abstract]
Revenue	$ 0	$ 0
Total revenue	0	0
OPERATING EXPENSES
General & administrative	555,681	948,895
Research & development	271,123	219,327
Total Operating Expenses	826,804	1,168,222
OTHER EXPENSES (INCOME)
Interest expense	304,646	4,917
Other income, net	(267)	(169)
Change in fair value of warrant liability	34,492	(136,500)
Change in fair value of put embedded in note payable	53,999	0
Settlement expense	115	38,437
Total Other Expenses (Income)	392,985	(93,315)
NET LOSS	(1,219,789)	(1,074,907)
Net loss	(1,219,789)	(1,074,907)
Deemed dividend on Series B Preferred Stock issuance	(708,303)	(1,067,491)
Accrued dividends on Series B Preferred Stock	(73,442)	(55,262)
Loss attributable to common shareholders	$ (2,001,534)	$ (2,197,660)
Net loss per share, basic and diluted	$ (1.08)	$ (1.21)
Weighted average of shares outstanding	1,847,140	1,809,257